# Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera

> **NCT00928707** · PHASE2 · COMPLETED · sponsor: **Italfarmaco** · enrollment: 45 (actual)

## Conditions studied

- Polycythemia Vera

## Interventions

- **DRUG:** GIVINOSTAT (ITF2357) 50 mg o.d. + MTD Hydroxyurea
- **DRUG:** GIVINOSTAT (ITF2357) 50 mg b.i.d. + MTD Hydroxyurea

## Key facts

- **NCT ID:** NCT00928707
- **Lead sponsor:** Italfarmaco
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-07
- **Final completion:** 2011-10
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00928707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00928707, "Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00928707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*